NMMP
Alternative Names: mocarhagin; NMM proteaseLatest Information Update: 30 Dec 2008
Price :
$50 *
At a glance
- Originator Wyeth
- Class Antiplatelets; Vascular disorder therapies
- Mechanism of Action GPIb receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 12 Jan 1999 Preclinical development for Thrombosis in USA (Unknown route)